Healthcare

in committee · United States · Senate Feb 12, 2025

S 553: SOLES Act

S 553, the SOLES Act, requires increased Medicare payments for sole community hospitals in Alaska and Hawaii. If a hospital's payment under Medicare's outpatient system is less than 94% of its reasonable costs, the payment must be raised to cover the shortfall. This directly affects the 11 sole community hospitals in these states that are the only providers of acute care in their communities. The bill mandates that these extra payments don't count toward budget neutrality rules or affect patient copayments, and requires the Secretary to issue implementing regulations within six months of enactment.

Topics ✓ Budget & TaxesSupports Budget & TaxesIncreases government spending on essential healthcare services by mandating higher Medicare payments for hospitals, exempting them from budget neutrality rules.90% confidence ✓ HealthcareSupports HealthcareIncreases Medicare payments for sole community hospitals to cover costs, preventing service cuts and ensuring acute care access in underserved Alaska/Hawaii communities.95% confidence

Sub-Topics Hospitals Medicare

Track

in committee · United States · Senate Jun 10, 2025

S 2006: Fit to Serve Act

S 2006, the Fit to Serve Act, prohibits the U.S. military from discriminating against service members or applicants based on gender identity. It directly affects all current and prospective members of the Armed Forces by banning specific discriminatory actions, including denying medically necessary health care, requiring service in a sex assigned at birth, or separating members due to gender identity (including gender dysphoria diagnosis). The bill amends Title 10 of the U.S. Code to add new protections, explicitly stating that the military cannot deny service, reenlistment, or health coverage based on gender identity. These changes apply uniformly across all branches and service statuses, ensuring equal treatment under military policy.

Topics ✓ HealthcareSupports HealthcareBill explicitly prohibits denying medically necessary healthcare related to gender identity, protecting access to required medical services for service members.95% confidence

Track

in committee · United States · House Feb 6, 2025

HR 211: Equal Access to Contraception for Veterans Act

HR 211, the Equal Access to Contraception for Veterans Act, eliminates out-of-pocket costs for specific contraceptives for veterans using VA healthcare. It amends Section 1722A of Title 38 to prohibit the VA from charging veterans copayments for contraceptive items that must be covered without cost-sharing under federal law (as required by Section 2713(a)(4) of the Public Health Service Act). This means veterans will not pay any amount for contraceptives covered by the federal mandate, such as birth control pills or IUDs, when obtained through the VA system. The bill directly affects veterans enrolled in VA healthcare seeking contraceptive services, ensuring no additional costs beyond what is already mandated for these items.

Topics ✓ HealthcareSupports HealthcareEliminates copayments for VA contraceptives, improving access to covered healthcare services under federal mandate.95% confidence ✓ VeteransSupports VeteransEliminates copayments for VA-covered contraceptives, enhancing healthcare access and benefits for veterans without cost barriers.95% confidence

Sub-Topics Insurance Public Health Women's Health Veteran Benefits Veteran Education Veteran Healthcare

Track

in committee · United States · Senate May 5, 2025

S 1587: Fair Prescription Drug Prices for Americans Act

The Fair Prescription Drug Prices for Americans Act would cap the U.S. list price for prescription drugs and biological products at the average price in Canada, France, Germany, Italy, Japan, and the United Kingdom. Drug manufacturers must annually report U.S. and international prices to the Health and Human Services Secretary, who calculates the six-country average. If a U.S. price exceeds this average, manufacturers face a civil penalty of 10 times the price difference per unit sold. The bill directly targets drug pricing practices without altering drug approval processes or insurance coverage.

Topics ✓ HealthcareSupports HealthcareCaps U.S. drug prices at international averages to lower costs, directly improving patient access to medications and reducing financial barriers in healthcare.95% confidence

Sub-Topics Insurance Prescription Drugs

Track

in committee · United States · Senate Dec 9, 2025

S 702: Veterans Mental Health and Addiction Therapy Quality of Care Act

This bill requires the Department of Veterans Affairs (VA) to commission an independent study comparing the quality of mental health and addiction therapy care provided by VA health care providers versus non-VA providers. The study must assess key factors like health outcome improvements, use of evidence-based practices, coordination between providers, veteran satisfaction, and care for veterans with co-occurring conditions. It will cover various treatment settings - including telehealth, inpatient, and outpatient care - and must be completed within 18 months, with results published publicly. The study directly affects veterans receiving mental health or addiction therapy services through VA or non-VA providers. The bill does not change benefits or funding but aims to gather data to inform future care decisions.

Topics ✓ HealthcareSupports HealthcareBill mandates VA to study mental health care quality comparison, aiming to improve outcomes, evidence-based practices, and veteran satisfaction for mental health services.95% confidence ✓ VeteransSupports VeteransMandates study to assess VA vs. non-VA mental health care quality, aiming to improve veteran treatment outcomes and services through evidence-based evaluation.95% confidence

Sub-Topics Mental Health Substance Abuse Telehealth Veteran Education Veteran Healthcare Veteran Mental Health

Track

in committee · United States · Senate Feb 19, 2025

S 641: Safe and Affordable Drugs from Canada Act of 2025

This bill, S 641 (Safe and Affordable Drugs from Canada Act of 2025), would allow U.S. individuals to import certain prescription drugs from Canada under specific conditions. It requires drugs to come from FDA-certified Canadian pharmacies, match U.S.-approved drugs in active ingredients and form, be for personal use (not resale) in 90-day quantities, and include a U.S. physician's prescription. The bill excludes controlled substances, biologics, infused drugs, and other high-risk medications. It directly affects U.S. patients seeking lower-cost prescriptions who meet these criteria. The FDA would establish the certification process for Canadian pharmacies within 180 days of enactment.

Topics ✓ HealthcareSupports HealthcareBill enables importation of affordable prescription drugs from Canada, improving patient access to lower-cost medications while ensuring safety standards.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · United States · Senate Feb 6, 2025

S 483: Responsibility in Drug Advertising Act of 2025

S 483, the Responsibility in Drug Advertising Act of 2025, prohibits direct-to-consumer advertising of newly approved drugs for the first three years after approval, with a possible waiver for the third year if the drug sponsor demonstrates public health benefits. After the initial three years, the FDA may ban such advertising if post-approval safety data shows significant health risks. The bill requires the FDA to update its advertising regulations within one year of enactment to implement these rules. It applies only to drugs approved under specific FDA pathways after a one-year cutoff before the law's effective date.

Topics ✓ HealthcareSupports HealthcareRestricts direct-to-consumer drug advertising for safety, aligning with public health protection in healthcare policy. Prohibits ads for 3 years to assess safety, promoting patient safety over marketing.85% confidence

Sub-Topics Public Health

Track

in committee · United States · Senate Jun 3, 2025

S 1929: SEPSIS Act

The SEPSIS Act establishes a dedicated sepsis program within the Centers for Disease Control and Prevention (CDC) to improve prevention, detection, and treatment of sepsis in hospitals. It requires hospitals to adopt evidence-based sepsis protocols (like the Hospital Sepsis Program Core Elements), report on their implementation, and supports pediatric sepsis data collection. The bill authorizes $20 million annually from 2026-2030 to fund CDC efforts, including annual reports to Congress on hospital adoption rates, pediatric sepsis reduction, and a voluntary "honor roll" program recognizing top-performing hospitals. This directly affects hospitals through reporting requirements and CDC through new program responsibilities.

Topics ✓ HealthcareSupports HealthcareFunds CDC sepsis program with $20M/year, mandates hospital protocols for prevention/treatment, directly advancing public health healthcare initiatives.95% confidence

Sub-Topics Children's Health Hospitals

Track

in committee · United States · Senate Mar 19, 2026

S 864: HELP Copays Act

The HELP Copays Act requires that financial assistance from non-profit organizations or prescription drug manufacturers counts toward patients' annual out-of-pocket cost-sharing limits (like deductibles and copays) for certain prescription drugs. It directly affects individuals enrolled in group health plans or individual insurance who receive such assistance, ensuring payments from these sources reduce their total out-of-pocket spending. The bill amends key healthcare laws to include these payments in calculating cost-sharing thresholds, specifically for specialty drugs and drugs subject to utilization management (like prior authorization). It takes effect for plan years beginning in 2026 and does not change how utilization management tools are applied.

Topics ✓ HealthcareSupports HealthcareBill ensures drug assistance counts toward out-of-pocket limits, reducing patient costs and improving medication access under healthcare coverage rules.95% confidence

Sub-Topics Prescription Drugs

Track

in committee · United States · House Sep 17, 2025

HR 5428: Medical Student Education Authorization Act of 2025

HR 5428 creates a federal grant program to support medical education for students planning to work in underserved areas. It provides $75 million annually (2026-2028) to accredited public medical schools in states with severe primary care physician shortages, prioritizing schools in states with multiple Indian Tribes and partnerships with tribal organizations or health centers. Grantees must use funds for community-based training, developing primary care programs emphasizing Tribal/rural underserved communities, faculty development, scholarships, and tracking graduates' practice locations. The bill directly affects medical schools and future physicians committed to serving Tribal, rural, or medically underserved communities after residency.

Topics ✓ EducationSupports EducationProvides $75M annually for medical education grants in underserved areas, directly funding higher education programs to expand access and address physician shortages.90% confidence ✓ HealthcareSupports HealthcareProvides $75M annually for medical education in underserved areas, directly improving healthcare access by addressing physician shortages through workforce development.95% confidence

Sub-Topics Medical Licensing Primary Care Tags Tribal Nations

Track